Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene Efficacy Study II (ESENSE 2)
NCT00812461Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Mar 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of nalmefene in alcohol dependence, sponsored by Lundbeck. Started Mar 2009; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00812461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812461.